Does high-dose extended course cyclophosphamide and methylprednisolone pulse therapy have a role in the management of systemic sclerosis-related interstitial lung disease?

Abignano, G, Bissell, L-A, Emery, P et al. (2 more authors) (2016) Does high-dose extended course cyclophosphamide and methylprednisolone pulse therapy have a role in the management of systemic sclerosis-related interstitial lung disease? Rheumatology, 55 (12). pp. 2273-2275. ISSN 1462-0324

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © The Author 2016. Published by Oxford University Press on behalf of the British Society for Rheumatology. This is a pre-copyedited, author-produced PDF of an article accepted for publication in Rheumatology following peer review. The version of record: Abignano, G, Bissell, L-A, Emery, P et al. (2 more authors) (2016) Does high-dose extended course cyclophosphamide and methylprednisolone pulse therapy have a role in the management of systemic sclerosis-related interstitial lung disease? Rheumatology, 55 (12). pp. 2273-2275, is available online at: https://doi.org/10.1093/rheumatology/kew362. Uploaded in accordance with the publisher's self-archiving policy.
Dates:
  • Accepted: 31 August 2016
  • Published (online): 15 October 2016
  • Published: December 2016
Institution: The University of Leeds
Depositing User: Symplectic Publications
Date Deposited: 24 Oct 2016 09:51
Last Modified: 18 Oct 2017 01:15
Published Version: https://doi.org/10.1093/rheumatology/kew362
Status: Published
Publisher: Oxford University Press
Identification Number: https://doi.org/10.1093/rheumatology/kew362

Export

Statistics


CORE (COnnecting REpositories)